# Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies

> **NCT00921739** · PHASE1 · COMPLETED · sponsor: **Duke University** · enrollment: 24 (actual)

## Conditions studied

- Non Small Cell Lung Cancer
- Small Cell Lung Cancer
- Thymoma
- Thymus Neoplasms

## Interventions

- **RADIATION:** Esophageal sparing IMRT

## Key facts

- **NCT ID:** NCT00921739
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09-11
- **Primary completion:** 2014-12
- **Final completion:** 2016-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00921739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00921739, "Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies". Retrieved via MORVS 2026-09-30 from https://api.morvs.ai/clinical/NCT00921739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*